Botanical species · safety record

Caesalpinia sappan

The EFSA Compendium of Botanicals holds 3 adverse-effect records for Caesalpinia sappan. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Caesalpinia sappan L.

0Constituent measurements

3Safety records

1Cited sources

19Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 19 licensed products naming Caesalpinia sappan as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA

Source material stated

Heartwood
Stem heartwood

What the records describe

Plant parts

Preparations

Effect types

Target tissues

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Hepatotoxicity	Liver	Wood	Solvent extraction	Rat (as animal)	Short-term toxicity	Resolve DOI
Other toxicities	Digestive	Wood	Solvent extraction	Rat (as animal)	Short-term toxicity	Resolve DOI
Other toxicities	Digestive	Wood	Solvent extraction	Rat (as animal)	Short-term toxicity	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Wang, You-Zhi., Sun, Shi-Qin., Zhou, Ya-Bin. Extract of the dried heartwood of Caesalpinia sappan L. attenuates collagen-induced arthritis. JOURNAL OF ETHNOPHARMACOLOGY, 2011, vol. 136, no. 1, p. 271-278. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature